Adrian Chabowski Selected Research

safingol (sphinganine)

6/2021	Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway.
1/2021	Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysis.
3/2013	Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian Chabowski Research Topics

Disease

52	Insulin Resistance 09/2022 - 07/2006
29	Obesity 09/2022 - 07/2004
15	Inflammation (Inflammations) 05/2022 - 01/2016
15	Non-alcoholic Fatty Liver Disease 03/2022 - 11/2012
12	Type 2 Diabetes Mellitus (MODY) 03/2022 - 09/2006
7	Neoplasms (Cancer) 01/2022 - 07/2008
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 03/2017
6	Fatty Liver 01/2022 - 01/2014
6	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2021 - 03/2017
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020 - 01/2014
5	Hypertension (High Blood Pressure) 04/2020 - 05/2016
4	Hyperglycemia 01/2022 - 07/2007
4	Liver Diseases (Liver Disease) 04/2021 - 01/2017
3	Body Weight (Weight, Body) 05/2022 - 01/2015
3	Morbid Obesity 01/2022 - 01/2018
3	Necrosis 09/2021 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2019
3	Leiomyoma (Uterine Fibroids) 01/2016 - 01/2012
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2022 - 03/2022
2	Neuroinflammatory Diseases 01/2022 - 06/2020
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 10/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2019
2	Overweight 12/2019 - 06/2007
2	Heart Failure 12/2018 - 02/2008
2	Carcinogenesis 10/2017 - 01/2012
2	Fibrosis (Cirrhosis) 01/2017 - 06/2014
2	Myocardial Infarction 05/2016 - 11/2011
2	Glucose Intolerance 04/2016 - 10/2015
2	Hyperlipidemias (Hyperlipidemia) 01/2015 - 01/2014
2	Hyperinsulinism (Hyperinsulinemia) 04/2011 - 07/2007
1	Atrial Fibrillation 09/2022
1	Diabetes Mellitus 09/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022

Drug/Important Bio-Agent (IBA)

57	LipidsIBA 09/2022 - 06/2006
32	CeramidesIBA 09/2022 - 06/2007
32	Fatty Acids (Saturated Fatty Acids)IBA 09/2022 - 07/2004
28	SphingolipidsIBA 09/2022 - 11/2012
24	Insulin (Novolin)FDA Link 05/2022 - 06/2007
18	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 06/2007
14	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2012
12	DiglyceridesIBA 04/2020 - 07/2007
11	Triglycerides (Triacylglycerol)IBA 01/2022 - 07/2004
10	Biomarkers (Surrogate Marker)IBA 03/2022 - 03/2017
8	AntioxidantsIBA 05/2022 - 01/2018
7	EndocannabinoidsIBA 03/2022 - 05/2016
7	PalmitatesIBA 08/2017 - 06/2006
6	thermozymocidin (myriocin)IBA 03/2017 - 01/2013
5	CannabidiolIBA 05/2022 - 01/2020
5	Streptozocin (Streptozotocin)FDA Link 10/2017 - 01/2014
4	Thioctic Acid (Lipoic Acid)IBA 05/2022 - 09/2021
4	EnzymesIBA 01/2022 - 10/2015
4	Fatty Acid-Binding ProteinsIBA 05/2021 - 01/2016
3	Carrier Proteins (Binding Protein)IBA 09/2022 - 01/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 06/2014
3	CytokinesIBA 01/2022 - 04/2009
3	Interleukin-6 (Interleukin 6)IBA 09/2021 - 03/2018
3	Palmitic Acid (Hexadecanoic Acid)IBA 06/2021 - 01/2019
3	safingol (sphinganine)IBA 06/2021 - 03/2013
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2021 - 01/2019
3	SphingosineIBA 01/2021 - 01/2013
3	SphingomyelinsIBA 08/2019 - 01/2015
3	AdipokinesIBA 04/2019 - 09/2017
3	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 03/2019 - 01/2017
3	ResveratrolIBA 01/2019 - 06/2014
3	LeptinIBA 01/2019 - 11/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 01/2012
3	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2015
3	Coenzyme A (CoA)IBA 01/2016 - 06/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2022 - 01/2014
2	Biological ProductsIBA 05/2022 - 03/2022
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2022 - 09/2018
2	CholesterolIBA 01/2022 - 02/2015
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 06/2020
2	CannabinoidsIBA 01/2021 - 01/2018
2	Phosphates (Orthophosphate)IBA 01/2021 - 03/2013
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2020 - 01/2018
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2019 - 04/2016
2	PolyphenolsIBA 01/2019 - 01/2017
2	AdiponectinIBA 01/2019 - 02/2009
2	Fatty Acid Binding Protein 3IBA 01/2016 - 11/2011
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2016 - 01/2015
2	O(2)- vinyl- 1- (pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA 07/2015 - 02/2015
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2015 - 03/2013
2	Metformin (Glucophage)FDA LinkGeneric 02/2015 - 07/2007
1	Matrix Metalloproteinases (MMPs)IBA 04/2022
1	GlobosidesIBA 01/2022
1	GangliosidesIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022

Therapy/Procedure

4	Therapeutics 02/2022 - 01/2017
2	Injections 04/2020 - 01/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 09/2022
1	Cryosurgery 09/2022
1	Intraperitoneal Injections 02/2022
1	Transplantation 01/2022